CommercialCoverageMedium impact
Bone Mineral Density Studies
Blue Cross & Blue Shield of Mississippi·MS · Family Medicine, Internal Medicine, Endocrinology +3 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy establishes comprehensive coverage guidelines for bone mineral density (BMD) studies, specifying when DEXA scans and other bone density tests are medically necessary. The policy covers screening intervals, risk factors, and approved testing methods for osteoporosis assessment.
Action Required
Billing team should review current bone density study claims to ensure they align with the specified medical necessity criteria including age requirements (women 65+, men 70+), risk factors from WHO FRAX model, and frequency limits (screening every 5 years, monitoring every 3 years, aromatase inhibitor monitoring every 2-3 years). Update prior authorization processes to verify patient meets established risk criteria before scheduling BMD studies.